Last reviewed · How we verify

NCT06646796

Yoga Impact in Fibromyalgia, Primary Health Care

Not yet recruiting NA Last updated 17 October 2024
What this trial tests

NA trial testing Yoga in Fibromyalgia in 20 participants. Not yet recruiting.

Timeline
1 December 2024
Primary endpoint
28 February 2025
30 April 2025

Quick facts

Lead sponsorUniversity of Coimbra
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposesupportive care
Enrollment20
Start date1 December 2024
Primary completion28 February 2025
Estimated completion30 April 2025
Sites1 location across Portugal

Drugs / interventions tested

Conditions studied

Sponsor

University of Coimbra

Who can join

18 and older, any sex, with Fibromyalgia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to evaluate the effectiveness of a complementary therapy using Yoga within the scope of First Health Care in Portugal, in pain control, quality of life and well-being of the patients with Fibromyalgia. It also, pretends to assess the viability and to identify the barriers to this sort of therapy in the context of Primary Health Care.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Yoga

Trials testing the same drug.

Other recruiting trials for Fibromyalgia

Currently open trials in the same condition.

Other University of Coimbra trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06646796.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing